EGFR Drug Resistance Detection Kit (Based on real-time PAP nucleic acid amplification)

Non-small cell lung cancer caused by activating mutations in the epidermal growth factor receptor gene (EGFR) are initially responsive to small molecule tyrosine kinase inhibitors (TKIs), but the efficacy of these agents is limited because of the emergence of drug resistance conferred by a second mutation, such as T790M.

Learn More